Suppr超能文献

[还脑益聪胶囊对老年轻度认知功能障碍的影响]

[Effect of huannao yicong capsule on senile mild cognitive impairment].

作者信息

Li Hao, Liu Fang, Xu Li-ran

机构信息

Xiyuan Hospital, China Academy of TCM, Beijing (100091).

出版信息

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004 Aug;24(8):689-93.

Abstract

OBJECTIVE

To observe the effect of Huannao Yicong capsule (HYC) on senile mild cognitive impairment.

METHODS

Sixty-two patients were randomly divided into two groups, the 31 patients in the treated group were treated with HYC 3 capsules, 3 times daily, and the 31 in the control group with Hydergin 3 tablets, 3 times daily. Treatment for two successive months was a therapeutic course. The changes of cognitive effect index (CEI), integral of measuring scale (CCSE, FQA and MMSE), TCM Syndrome scoring, quality of life (QOL), cerebral arterial blood flow (CBF) and hemorrheologic parameters in the two groups were observed.

RESULTS

The total effective rate of treatment in improving cognition in the 30 patients of the treated group (with one case lost) was 83.33%, while that in the 29 patients of the control group (with two cases lost) was 48.28%, the difference between them was significant (u = 2.36, P < 0.05). Intent-to-treat analysis, namely, the case lost in the treated marked as ineffective and those in the control group as effective, showed the total effective rate in the two groups was 80.65% and 51.61% respectively, which also showed significant difference (u = 2.02, P < 0.05). In the treated group after treatment, the integrals of CCSE, FAQ and MMSE significantly increased (P < 0.05 or P < 0.01), the TCM Syndrome scoring decreased (P < 0.01), the scoring of QOL significantly improved, the mean BBF increased (P < 0.05 or P < 0.01), and the cerebral arterial resistance index improved significantly. All these improvements in the treated group were significantly higher than those in the control group respectively (P < 0.05). Besides, the hemorrheologic parameters in the treated group were improved, most of them were better than those in the control group (P < 0.05 or P < 0.01).

CONCLUSION

HYC has good therapeutic effect on senile mild cognitive impairment, it is safe without any adverse reaction.

摘要

目的

观察还脑益聪胶囊(HYC)对老年轻度认知功能障碍的影响。

方法

将62例患者随机分为两组,治疗组31例,服用还脑益聪胶囊,每次3粒,每日3次;对照组31例,服用喜得镇,每次3片,每日3次。连续治疗2个月为1个疗程。观察两组认知功能疗效指数(CEI)、量表积分(CCSE、FQA和MMSE)、中医证候评分、生活质量(QOL)、脑动脉血流(CBF)及血液流变学参数的变化。

结果

治疗组30例(失访1例)认知功能改善的总有效率为83.33%,对照组29例(失访2例)为48.28%,两组比较差异有统计学意义(u = 2.36,P < 0.05)。意向性分析,即治疗组失访病例按无效计算,对照组失访病例按有效计算,两组总有效率分别为80.65%和51.61%,差异有统计学意义(u = 2.02,P < 0.05)。治疗组治疗后CCSE、FAQ和MMSE积分显著升高(P < 0.05或P < 0.01),中医证候评分降低(P < 0.01),QOL评分显著改善,平均CBF增加(P < 0.05或P < 0.01),脑动脉阻力指数显著改善。治疗组上述各项改善均显著高于对照组(P < 0.05)。此外,治疗组血液流变学参数得到改善,多数优于对照组(P < 0.05或P < 0.01)。

结论

还脑益聪胶囊对老年轻度认知功能障碍有良好的治疗作用,安全无不良反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验